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ARTICLE
Diversity in medullary thymic epithelial cells
controls the activity and availability of iNKT cells
Beth Lucas1, Andrea J. White1, Emilie J. Cosway1, Sonia M. Parnell1, Kieran D. James1, Nick D. Jones1,
Izumi Ohigashi2, Yousuke Takahama3, William E. Jenkinson1 & Graham Anderson 1✉
The thymus supports multiple αβ T cell lineages that are functionally distinct, but mechanisms
that control this multifaceted development are poorly understood. Here we examine medullary
thymic epithelial cell (mTEC) heterogeneity and its influence on CD1d-restricted iNKT cells.
We find three distinct mTEClow subsets distinguished by surface, intracellular and secreted
molecules, and identify LTβR as a cell-autonomous controller of their development. Impor-
tantly, this mTEC heterogeneity enables the thymus to differentially control iNKT sublineages
possessing distinct effector properties. mTEC expression of LTβR is essential for the devel-
opment thymic tuft cells which regulate NKT2 via IL-25, while LTβR controls CD104+
CCL21+ mTEClow that are capable of IL-15-transpresentation for regulating NKT1 and NKT17.
Finally, mTECs regulate both iNKT-mediated activation of thymic dendritic cells, and iNKT
availability in extrathymic sites. In conclusion, mTEC specialization controls intrathymic iNKT
cell development and function, and determines iNKT pool size in peripheral tissues.
https://doi.org/10.1038/s41467-020-16041-x OPEN
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A key feature of the adaptive immune system is thedevelopment of αβT cells in the thymus. Here, specialisedcortical and medullary thymic microenvironments sup-
port the step-wise maturation of self-tolerant CD4+ and CD8+
αβT cells that recognise peptide/major histocompatibility com-
plex (MHC) ligands. Studies on thymic epithelial cell (TEC)
heterogeneity have yielded several underlying features that
determine their ability to control specific events in conventional
αβT cell development1–3. For example, in medullary TECs
(mTECs), expression of Aire together with high levels of CD80/
CD86 and MHC explains the functional importance of mTEChi
for tolerance induction4–6. In addition to generating and shaping
the conventional αβT cell pool, thymic microenvironments also
foster other T cell lineages that are classed as ‘unconventional’ as
they express antigen receptors that do not recognise MHC. These
include CD1d-restricted invariant natural killer T cells
(iNKT cells) that via their steady-state production of cytokines,
including interleukin-4 (IL-4)7–9, play important roles in the
control of immune responses10,11. Thus, the thymus is critical for
the generation of multiple αβT cell types that play key roles in the
functioning of both the innate and adaptive arms of the immune
system. Despite this, how the thymus controls diversity in T cell
production remains poorly understood.
Here, we show that lymphotoxin β receptor (LTβR) is an
essential regulator of multiple mTEC subsets within the
CD80lowMHCIIlow mTEClow compartment, including thymic tuft
cells and the CCL21+ subset. Importantly, we provide evidence
that mTEClow heterogeneity is accompanied by functional spe-
cialisation. Thus, PLZFhiRORγt−Tbet− NKT2 are regulated by
IL-25 production by thymus tuft cells, providing an explanation
for the requirement for this newly described mTEC subset in
iNKT cell development. Additionally, PLZFlowRORγt−Tbet+
NKT1 and PLZFlowRORγt+Tbet− NKT17 are influenced by IL-
15 transpresentation, with CCL21+CD104+ mTEClow identified
as mTECs with this function. Finally, LTβR-mediated mTEC
heterogeneity enables iNKT cells to control intrathymic dendritic
cell (DC) activation, and establishment of the peripheral iNKT
cell pool. Collectively, our findings identify the regulation of
mTEC heterogeneity by LTβR as an intrathymic mechanism that
determines the availability and function of iNKT cells in both the
thymus and periphery.
Results
Heterogeneity in the adult mTEClow compartment. Tradition-
ally, mTECs in the adult thymus are divided into MHCII-
lowCD80low and MHCIIhiCD80hi (mTEClow/mTEChi) subsets6,12.
While mTEChi control tolerance induction through negative
selection of conventional αβT cells and the generation of Foxp3+
regulatory T cells13,14, the functional importance of the mTEClow
compartment remains poorly understood. Indeed, despite reports
on mTEClow heterogeneity from RNA-sequencing data15,16,
attempts to study their functional specialisation are limited by a
current inability to identify, isolate and study individual mTEClow
subsets.
To address this, we examined mTEClow in the 8–12-week adult
mouse thymus. By screening disaggregated TEC-enriched cell
suspensions for reactivity with antibodies to surface, secreted and
intracellular factors, we identified two distinct mTEClow subsets
distinguished by their differential cell surface expression of the
integrin β4 (CD104) (Fig. 1a), shown previously to be expressed
by TECs within the mTEC compartment16. Importantly, further
analysis showed that CD104+ mTEClow, but not CD104−
mTEClow, could also be defined by their intracellular expression
of CCL21 (Fig. 1a), a chemokine essential for the recruitment of
positively selected thymocytes into the medulla17. Thus, CD104
expression in mTEClow defines a functionally important CCL21-
expressing mTEClow subset that can be readily isolated by cell
sorting. Furthermore, we found that thymic tuft cells15,16, defined
here by the expression of the tuft cell-specific enzyme DCLK118,
were detectable specifically within the CD104−CCL21− mTEClow
subset (Fig. 1a). A CD104−CCL21−DCLK1− ‘triple-negative’
mTEClow subset was also detectable (Fig. 1a). Interestingly, flow
cytometric analysis showed that thymic tuft cells were markedly
absent from the CD104+CCL21+ mTEClow subset (Fig. 1a). In
agreement with this, we detected the expression of the tuft cell
signature genes, Pou2f3, Dclk1 and Trpm519,20, in FACS
(fluorescence-activated cell sorting)-sorted CD104−, but not in
CD104+ mTEClow (Fig. 1b). Furthermore, immunofluorescence
confocal analysis of adult thymus tissue sections from
CCL21tdTOM reporter mice confirmed the non-overlapping
nature of DCLK1+ thymic tuft cells and CCL21+ TEC subsets,
and showed individual tuft cells embedded within a network of
CCL21+ mTECs (Fig. 1c). Finally, comparison of the ontogenetic
appearance and frequency analysis of mTEClow subsets identified
CD104+CCL21+ cells as the dominant mTEClow population
from birth onwards, followed by CD104−CCL21−DCLK1− cells,
with the frequency of both populations remaining constant in this
period (Fig. 1d). In contrast, and in agreement with other
studies15,16, we found that thymic tuft cells were barely detectable
in the neonatal thymus, but then increased in proportion and
number during adulthood (Fig. 1d). Collectively, these data define
discrete populations within the mTEClow compartment of adult
mice, and offers opportunities for their isolation and examination
of their functional properties.
LTβR is a critical regulator of multiple mTEClow subsets. To
assess the developmental requirements and functional properties
of the mTEC subsets described above, we analysed their expres-
sion of LTβR, a known regulator of the mTEC lineage21–23. All
mTEClow subsets expressed LTβR, with the highest levels detect-
able on thymic tuft cells (Supplementary Fig. 1). To examine the
potential importance of LTβR expression in the control of mTE-
Clow development, we generated Foxn1CreLTβRfl/fl ‘LTβRTEC’
mice, where the absence of LTβR in the thymus is selective to the
TEC compartment22. In particular, given the ability to use a
combination of DCLK1/CD104/CCL21 expression to positively
identify both thymic tuft cells and CD104+CCL21+ mTECs, we
focussed our attention on these two mTEClow subsets. Strikingly,
in both flow cytometric (Fig. 2a) and confocal analysis (Fig. 2b),
we found that thymic tuft cells were absent from the thymus of
LTβRTEC mice. In agreement with this importance of LTβR, tuft
cells were also absent from the thymus of germline Ltbr−/− mice
(Supplementary Fig. 2). Consistent with the absence of tuft cells
in LTβRTEC thymus, messenger RNA (mRNA) expression of tuft
cell genes, Pou2f3, Dclk1 and Trpm5, was absent from CD104−
mTEClow isolated from LTβRTEC mice (Fig. 2c). Collectively,
these findings indicate that TEC expression of LTβR is important
for thymic tuft cell development. However, as LTβR is expressed
by multiple mTEC populations22, including tuft cells (Supple-
mentary Fig. 1a), it is not clear where in the mTEC developmental
pathway LTβR is required for tuft cell development. As a first
step to further understand how and when LTβR is important
for thymus tuft cell generation, we stimulated alymphoid 2-
deoxyguanosine (2dGuo)-treated foetal thymic organ culture
(FTOC) for 4 days with an agonistic anti-LTβR antibody24. As
2dGuo FTOC lack tuft cells (Fig. 2d) but contain mTEC pro-
genitors25, this approach provided an initial opportunity to see if
LTβR stimulation of mTEC progenitors can induce tuft cell
development. As an indicator of the efficacy of antibody treat-
ment of these cultures, anti-LTβR stimulation had a positive
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effect in FTOC, as indicated by strong upregulation of Ccl21a
mRNA (Fig. 2e). However, we found that anti-LTβR stimulation
did not induce the appearance of thymic tuft cells, as indicated by
the absence of DCLK1+ cells by flow cytometry (Fig. 2d), and the
absence of Pou2f3 and Dclk1 mRNA by quantitative polymerase
chain reaction (qPCR) (Fig. 2e). Collectively, these findings
demonstrate that while LTβR is an important regulator of thymic
tuft cell development, LTβR stimulation of 2dGuo FTOC that
contain mTEC progenitors is not sufficient for their development.
We next examined how LTβR expression might influence the
development of other mTEClow subsets. Of particular relevance
here, while germline Ltbr−/− mice have a reported reduction in
CCL21+ mTEClow26, the absence of LTβR expression from all cell
types due to germline deficiency did not allow for discrimination
between TEC-intrinsic and TEC-extrinsic roles for LTβR in
mTEC regulation. To address this, we examined CD104+CCL21+
mTEClow in LTβRTEC mice, where in the thymus LTβR is
selectively absent from TEC. While the percentage of these cells
within the total adult mTEClow compartment was comparable
between Foxn1Cre controls and LTβRTEC mice, their absolute
numbers were reduced in the latter (Fig. 3a). Interestingly, despite
this numerical difference, levels of both CCL21 protein (Fig. 3b)
and mRNA (Fig. 3c) were comparable in CD104+CCL21+
mTEClow, which were isolated from LTβRTEC mice and Foxn1Cre
controls. Thus, while LTβR may not be an absolute requirement
for the developmental emergence of CD104+CCL21+ mTEClow,
including their expression of the chemokine CCL21, it represents
an important regulator of the intrathymic availability of these
cells. Consistent with this, and the induction of Ccl21a mRNA
(Fig. 2f), stimulation of 2dGuo FTOC with agonistic anti-LTβR
caused a significant increase in the number of CD104+CCL21+
mTEClow (Fig. 3d). Finally, given that LTβRTEC mice show
combined deficiencies in both thymic tuft cells and CD104+
CCL21+ mTEClow, we wondered whether the reduction in
CD104+CCL21+ mTEClow in LTβRTEC mice may be a con-
sequence of the absence of DCLK1+ thymic tuft cells. To address
this, we examined the mTEClow compartment of Pou2f3−/− mice
that lack tuft cells27. Interestingly, while thymic tuft cells were
absent from these mice as expected, CD104+CCL21+ mTEClow
were present in normal numbers (Supplementary Fig. 3).
Collectively, these data identify LTβR as an important regulator
of the mTEC lineage through its control of cellular heterogeneity
within the mTEClow compartment.
LTβR in thymic epithelium controls intrathymic iNKT cells. In
the adult thymus, mTECs play well-defined roles in conventional
αβT cell development4,17. However, their influence on other
functions of the thymus medulla is poorly understood. In parti-
cular, it is not clear whether the requirement for mTECs in the
development of conventional αβT cells is similar to, or distinct
from, their importance for non-conventional T cell develop-
ment28. To study this, we examined how LTβR-mediated control
of mTEC diversity might affect the intrathymic development of
CD1d-restricted iNKT cells that depend upon medullary micro-
environments28. We used flow cytometry and PBS57/CD1d tet-
ramers to specifically identify iNKT cells in thymocyte
suspensions from adult LTβRTEC and Foxn1Cre control mice.
Using this approach, we saw a striking reduction in the percen-
tage and absolute number of iNKT cells in the thymus of
LTβRTEC mice (Fig. 4a, b). Next, we subdivided total PBS57/
CD1d+ iNKT cells into distinct subsets on the basis of expression
of the transcription factors PLZF, Tbet and RORγt, to
identify Tbet+ NKT1, PLZFhi NKT2 and RORγt+
NKT17 sublineages7,8,29,30. Interestingly, we saw that the reduc-
tion in total intrathymic iNKT cells was a result of an equivalent
(~3–4-fold) reduction in all three iNKT sublineages (Fig. 4b).
Importantly, this reduction in iNKT cell numbers in the thymus
of LTβRTEC mice was not due to a reduction in the numbers of
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Fig. 1 The adult mTEClow compartment is phenotypically diverse. a EpCAM1+Ly51−UEA1+ total mTECs from digested adult C57/BL6 (WT) thymus were
subdivided into mTEClow and mTEChi on the basis of MHCII and CD80 expression. Cell surface (CD104) and intracellular (DCLK1 and CCL21) expression
within total mTEClow is shown, which identifies three mTEClow subsets: CD104+CCL21+ cells (blue), CD104−CCL21−DCLK1+ thymic tuft cells (magenta)
and CD104−CCL21−DCLK1− ‘triple-negative’ cells (green). b qPCR analysis showing mRNA levels of the tuft cell signature genes Pou2f3, Dclk1 and Trpm5 in
CD104+ and CD104− mTEClow subsets that were FACS sorted from WT adult thymus, data are representative of three biological sorts. c Confocal
microscopy of frozen tissue sections of adult CCL21tdTOM thymus stained with antibodies to DCLK1 (cyan), representative of n= 3 independent biological
samples. Counterstaining with DAPI is in blue, CCL21tdTOM is in magenta and scale bars denote 20 μm. d Analysis of the ontogenetic frequency of
mTEClow subsets identified in a, WT mice of 1 day, 1 week, 2 week, 4 week and 8 week were analysed, CD104+CCL21+ cells: 1 day n= 10, 1 week n= 10,
2 week n= 7, 4 week n= 7, 8 week n= 6, tuft cells: 1 day n= 9, 1 week n= 9, 2 week n= 6, 4 week n= 7, 8 week n= 10, triple-negative cells: 1 day n= 6,
1 week n= 6, 2 week n= 6, 4 week n= 6, 8 week n= 7, over three independent experiments per age. All data are represented as mean ± SEM. Source data
are provided as a Source Data file.
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CD4+CD8+ thymocytes that give rise to iNKT cells (Supple-
mentary Fig. 4). Moreover, and in agreement with previous stu-
dies demonstrating the predominant medulla localisation of
iNKT cells in wild-type (WT) mice8, iNKT cells in both Foxn1Cre
controls and LTβRTEC mice were within medullary thymic areas
(Supplementary Fig. 4), arguing against the idea that the observed
iNKT cell defects are caused by failure to enter the thymus
medulla.
To examine how LTβR-mediated control of mTEClow might
impact iNKT cell development, we examined both cell types for
their expression of corresponding receptor/ligand pairs that
might explain the iNKT cell defect in LTβRTEC mice. First, we
analysed cytokine receptor expression by NKT1, NKT2 and
NKT17 subsets using flow cytometry. We found IL-17RB, a
receptor for the cytokine IL-25 that increases splenic iNKT cell
numbers in vitro31,32, was expressed by both thymic NKT2 and
NKT17, but not NKT1 (Fig. 4c). By contrast, the expression of
CD122, a component of the receptor for IL-15 that drives iNKT
cell proliferation7,33,34, was expressed by all iNKT sublineages,
with the highest expression in NKT1 (Fig. 4d). Next, we analysed
mTEC subsets for expression of corresponding cytokines that
interact with the receptors described above. Consistent with the
presence of thymic tuft cells in this population, we found CD104−
mTEClow isolated from WT mice expressed the tuft cell-specific
cytokine IL-25 (Fig. 4e). Moreover, CD104− mTEClow isolated
from LTβRTEC mice did not express Il25 mRNA (Fig. 4f), a
finding in agreement with the lack of thymic tuft cells in these
mice (Fig. 2). In contrast, compared to CD104− mTEClow,
mRNA levels of Il15 and Il15ra that collectively facilitate IL-15
transpresentation29,30 were highest in CD104+mTEClow (Fig. 4e).
Interestingly, Il15 and Il15ra mRNA levels in CD104+ mTEClow
from LTβRTEC mice were comparable to that seen in Foxn1Cre
controls (Fig. 4f). Thus, within mTEC, IL-25 and IL-15
transpresentation are controlled by LTβR in different ways. First,
IL-25 expression in the thymus is LTβR dependent as a
consequence of its essential role in thymic tuft cell development.
Second, LTβR can influence IL-15 transpresentation in the
thymus not by direct control of Il15/Il15ra mRNA expression, but
by controlling the frequency of CD104+CCL21+ mTEClow that
express these genes.
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Fig. 2 LTβR regulates thymic tuft cell development. a Intracellular staining of mTEClow from control Foxn1Cre and LTβRTEC mice for expression of the tuft
cell marker DCLK1. Bar graphs indicate absolute cell numbers and percentages within mTEClow in Foxn1Cre mice (closed symbols) and LTβRTEC mice (open
symbols) n= 7 biologically independent samples, over three independent experiments. Significant P values using two-tailed unpaired t test as follows: no.
of tuft cells p= 0.0001, % tuft cells p= 0.002. b Confocal image of thymus section from Foxn1Cre and LTβRTEC mice, stained for the mTEC marker ERTR5
(magenta) and DCLK1 (cyan), representative of n= 3 independent biological samples. Scale bars denote 20 μm. c qPCR analysis of CD104− mTEClow
FACS sorted from Foxn1Cre (closed symbols) and LTβRTEC (open symbols) mice, for expression of the tuft cell markers Pou2f3, Dclk1 and Trpm5, data are
representative of three biological sorts. d Alymphoid 2dGuo-treated FTOC cultured for 4 days in the presence or absence of agonistic anti-LTβR (2 μg/ml)
were analysed by flow cytometry for intracellular expression of DCLK1 to detect tuft cells. Tuft cells in freshly isolated adult WT mTEClow are shown for
comparison, data are representative of three independent experiments. e qPCR analysis of control (closed circles) and anti-LTβR stimulated (open circles)
dGuo FTOC for expression of Pou2f3 and Dclk1, with levels of mRNA expression in adult mTEClow (closed squares) for comparison, data are representative
of three biological sorts from six FTOC cultured lobes/sort. f qPCR analysis of control (closed cirlces) and anti-LTβR stimulated (open circles) dGuo FTOC
for expression of Ccl21a. All data are represented as mean ± SEM. ***P < 0.001 and **P < 0.01. Source data are provided as a Source Data file.
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Specialisation of mTEClow influences iNKT cell sublineages.
Next, we investigated the importance of individual mTEClow
subsets and their products on the intrathymic development of
specific iNKT subsets. First, we analysed NKT1, NKT2 and
NKT17 sublineages in the thymuses of adult WT and tuft cell-
deficient Pou2f3−/− mice. Relevant to this, a previous study15
showed a reduction in NKT1, NKT2 and NKT17 in the thymus of
Pou2f3−/− mice. Consistent with this earlier study, we found a
reduction in NKT2 (Fig. 5a, b), but in contrast to that reported by
Miller et al.15, we did not find alterations in NKT1 or NKT17
(Fig. 5a, b). Importantly, while both studies demonstrate a role for
tuft cells in NKT2 development in the thymus, the mechanism is
not known. As tuft cells are the exclusive producers of IL-25 in the
thymus15,16, and as both NKT2 and NKT17 express high levels of
IL-25 receptor (IL-17RB) (Fig. 4), we wondered whether this
requirement for tuft cells could be explained by their IL-25 pro-
duction, by examining thymic iNKT cell development in Il25−/−
mice. Here, it is important to note that we used Balb/C WT and
Il25−/− mice on a Balb/c background, which as reported pre-
viously7 results in skewing of iNKT cells towards NKT2. Impor-
tantly, while NKT1 and NKT17 were unaltered compared to WT
controls, we found a significant and selective NKT2 decrease in
the thymus of Il25−/− mice. This fits well with previous obser-
vations demonstrating a selective NKT2 cell reduction in IL-
17RB-deficient mice35. Taken together, these findings suggest that
at least one of the requirements for tuft cells in thymic NKT2
development can be explained by their provision of IL-25.
Given this reduction in NKT2 in Il25−/− mice, we also
investigated whether diminished numbers of NKT2 in LTβRTEC
mice might be restored through the addition of IL-25. As all
iNKT sublineages are reduced in LTβRTEC mice (Fig. 4), they
were chosen as the ‘rescue’ model for these experiments to see
whether cytokine administration might restore multiple iNKT
subsets in the same thymus, with any effects then being related to
the mTEC defects in these mice. Thus, adult LTβRTEC mice were
injected with either phosphate-buffered saline (PBS) or a single
dose of IL-25, and we analysed intrathymic iNKT cells 4 days
later. Treatment with recombinant IL-25 in vivo caused a
significant and selective increase in NKT2 numbers in LTβRTEC
mice, but did not alter numbers of either NKT1 or NKT17,
despite robust expression of the IL-25 receptor by the latter
(Fig. 5c, d). Interestingly, in vitro treatment of thymocyte
suspensions with IL-25 neither increased nor maintained NKT2
cell numbers. Rather, we saw a progressive decline in all iNKT cell
sublineages over a 3-day culture period (Fig. 5e). Thus, provision
of IL-25 in vivo is sufficient to rescue the NKT2 deficiency in
LTβRTEC mice, but does not promote their rescue in vitro,
suggesting that additional intrathymic factors that are not present
in suspension also influence NKT2 cells.
While IL-15 transpresentation can increase thymic NKT28, it is
not known whether this is as a result of selective effects on NKT1,
NKT2 and/or NKT17. To address this, we injected LTβRTEC mice
with a single dose of IL-15/IL-15Rα complex (Fig. 6a). After
4 days, we saw a significant increase in both thymic NKT1 and
NKT17 (Fig. 6b, c), with NKT2 unchanged (Fig. 6b, c). Thus,
in vivo provision of IL-15 transpresentation is sufficient to at least
partially restore the thymic defect in NKT1 and NKT17 in
LTβRTEC mice. Interestingly, we found that in vitro addition of
IL-15/IL-15Rα complexes to thymocyte suspensions from
LTβRTEC mice significantly increased NKT1 (Fig. 6d, e). More-
over, NKT1-treated in vitro with IL-15/IL-5Rα showed increased
levels of Bcl2 protein (Fig. 6f), together with an increased
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Fig. 3 Impaired production Of CD104+CCL21+ mTEClow In LTβRTEC mice. amTEClow from Foxn1Cre and LTβRTEC mice, analysed for surface expression of
CD104 and intracellular expression of CCL21. Bar graphs show cell percentages and absolute cell numbers in Foxn1Cre (n= 6 biologically independent
samples, closed symbols) and LTβRTEC mice (n= 6 biologically independent samples, open symbols), over three independent experiments. Significant
P values using two-tailed unpaired t test are as follows: no. of cells P= 0.0009. bMFI levels of intracellular CCL21 expression in pre-gated CD104+CCL21+
mTEClow from Foxn1Cre (closed symbols) and LTβRTEC (open symbols) mice, n= 6 biologically independent samples, over three independent experiments.
c Levels of Ccl21 mRNA in FACS sorted CD104+ mTEClow from Foxn1Cre (closed symbols) and LTβRTEC mice (open symbols), data representative of three
biological sorts. d Alymphoid 2dGuo-treated FTOC cultured for 4 days in the presence or absence of agonistic anti-LTβR (2 μg/ml) were pooled and
analysed by flow cytometry for the expression of CCL21 and CD104. Freshly isolated adult WT mTEClow were stained alongside for comparison. Significant
P values using two-tailed unpaired t test are as follows: % cells P= 0.0003, no. of cells P= 0.0102. Six FTOC cultured lobes were pooled per data point,
n= 3 biologically independent samples, over three independent experiments. All data are represented as mean ± SEM. *P < 0.05 and ***P < 0.001. Source
data are provided as a Source Data file.
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frequency of Ki67+ cells (Fig. 6g), suggesting that IL-15
transpresentation regulates NKT1 by controlling their survival
and proliferation. Interestingly, and in contrast to in vivo effects,
in vitro IL-15/IL-15R treatment did not increase NKT17,
suggesting that additional intrathymic factors may also be
required alongside IL-15 transpresentation that regulate NKT17
numbers.
mTEClow control iNKT cell function and availability. The data
above suggest that iNKT cell availability in the thymus can be
controlled by subset specialisation in mTEClow, which in turn is
regulated by TEC expression of LTβR. We speculated that this
axis might represent an important mechanism that then controls
the functioning of iNKT cells within multiple tissues. To examine
this, we looked in both the thymus and peripheral tissues of
LTβRTEC mice for evidence of alterations in iNKT cell function.
In the thymus, we focussed attention on DCs as IL-4, a cytokine
produced constitutively by thymic iNKT cells, is a known reg-
ulator of chemokine production by thymic DCs7. We performed
flow cytometric analysis of digested thymus preparations to
identify CD11c+PDCA1− conventional DCs (cDCs) within the
intrathymic DC pool, which we then separated into Sirpα−
(cDC1) and Sirpα+ (cDC2) subsets36,37. Consistent with our
previous study22, we found that while total numbers of thymic
DCs were not significantly altered in LTβRTEC mice, there was a
significant increase in the number of cDC2. Interestingly, how-
ever, we found that the activation status of both cDC1 and cDC2
was diminished in the thymus of LTβRTEC mice, as indicated by a
reduction in the frequency of MHCIIhiCD86hi cells (Fig. 7a). To
correlate these differences in DC activation to the defects in
iNKT cells in LTβRTEC mice, we next analysed intrathymic DC in
Cd1d1−/− mice. Importantly, these mice have been shown to lack
a
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Fig. 4 LTβR expression by thymic epithelium controls the intrathymic iNKT cell pool. a Thymocytes from Foxn1Cre and LTβRTEC mice, analysed for
expression of TCRβ and reactivity with the PBS57-loaded CD1d tetramer to identify iNKT cells. TCRβ+PBS57:CD1d+ cells were analysed for intracellular
expression of PLZF, Tbet and RORγt to identify NKT1, NKT2 and NKT17 subsets as indicated. b Absolute numbers of iNKT cells and iNKT subsets in
Foxn1Cre controls (n= 11 biologically independent samples, closed symbols) and LTβRTEC mice (n= 12 biologically independent samples, open symbols),
over three independent experiments. Percentages relative to Foxn1Cre controls are also shown. Significant P values using two-tailed unpaired t test as
follows: no. of total iNKT P= 0.0002, no. of NKT1 P= 0.0003, no. of NKT2 P≤ 0.0001, no. of NKT17 P= 0.0021, % Total iNKT P= 0.0001, % NKT1 P=
0.0003, % NKT2 P≤ 0.0001, % NKT17 P= 0.0021. c Levels of expression of IL-17RB (IL-25R) on iNKT subsets; grey histograms represent isotype
controls. Bar graphs show MFI of IL-17RB on indicated iNKT subsets, n= 5 biologically independent samples, over three independent experiments.
Significant P values using two-tailed unpaired t test as follows: NKT1 vs. NKT2 P≤ 0.0001, NKT1 vs. NKT17 P= 0.0005. d Levels of CD122 expression on
iNKT cell subsets; grey histograms represent isotype controls. Bar graphs show MFI of CD122 on indicated iNKT subsets, n= 5 biologically independent
samples, over three independent experiments. Significant P values using two-tailed unpaired t test as follows: NKT1 vs. NKT2 P≤ 0.0001, NKT1 vs. NKT17
P= 0.0004. e qPCR analysis of Il25, Il15 and Il15ra mRNA in CD104+ (closed symbols) and CD104− (open symbols) mTEClow isolated from adult WT
mice. f qPCR analysis of Il25 in CD104− mTEClow, and expression of Il15 and IL15ra in CD104+ mTEClow from control Foxn1Cre (closed symbols) and
LTβRTEC mice (open symbols). All data are represented as mean ± SEM, **P < 0.01, ***P < 0.001 and ****P < 0.0001. qPCR was performed in replicate, and
data shown are representative of three independent biological sorted samples. Source data are provided as a Source Data file.
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iNKT cells and have been used extensively as a model to study
mechanisms that control iNKT cell development in the
thymus7,28. In these experiments, to avoid any potential con-
founding problems caused by genetic haploinsufficiency, we used
WT mice as controls rather than Cd1d1 heterozygotes. When we
analysed DC activation in Cd1d1−/− mice, we found that it was
reduced in a manner comparable to that seen in LTβRTEC mice
(Fig. 7b). Thus, these findings further emphasise the regulation of
thymic DC by iNKT cells, and suggest that DC deficiencies in
LTβRTEC mice may be explained by their deficiencies in
iNKT cells.
Perhaps, most significantly, we saw that LTβRTEC mice had
significant deficiencies in iNKT cells in all peripheral tissues
examined, including spleen, lung, liver and peripheral blood
(Fig. 8a, b). Thus, despite selective targeting of LTβR deletion by
Foxn1Cre, which targets only the thymus and skin38, defects in
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iNKT cells in the thymus of LTβRTEC mice are accompanied by
long-term iNKT cell defects in extrathymic tissues. Interestingly,
splenic iNKT cells in Foxn1Cre and LTβRTEC mice responded
equally well to in vivo αGal-Cer stimulation in terms of per cell
levels of IL-4 and interferon-γ (IFNγ) expression (Fig. 8c, d). In
contrast, and in agreement with the reduced iNKT peripheral
pool size, fewer IL-4+ and IFNγ+ cells (Fig. 8e), and lower levels
of serum IL-4 and IFNγ (Fig. 8f), were detected in LTβRTEC mice
following αGal-Cer stimulation. Thus, despite their reduced
frequency in LTβRTEC mice, iNKT cells are functionally
competent in terms of their cytokine production in response to
in vivo T cell receptor (TCR) stimulation. Collectively, our data
identify an intrathymic mechanism in which LTβR regulates
subset specialisation in mTEC, which not only controls iNKT cell
development and function in the thymus but also iNKT cell
availability in peripheral tissues.
Discussion
In contrast to the known importance of mTEChi in thymic
tolerance4,6,12, functional specialisation in mTEClow is poorly
understood. To address this, we examined the adult mTEClow
compartment and the molecular mediators that control it. Next,
Fig. 5 IL-25 production from thymic tuft cells controls intrathymic iNKT2 cells. Flow cytometric detection (a) and quantitation (b) of TCRβ+PBS57:CD1d
tetramer+ iNKT cells and NKT1, 2 and 17 subsets in WT (n= 8 biologically independent samples, closed symbols) and tuft cell-deficient Pou2f3−/− (n= 7
biologically independent samples, open symbols), over three indepdendent experiments. Significant P values using two-tailed unpaired t test as follows: no.
of NKT2 P= 0.0033 and % NKT2 P= 0.0253. Flow cytometric detection and quantitation (c) of total iNKT and iNKT subsets in BALB/c WT (n= 9
biologically independent samples, closed symbols) and Il25−/− (n= 7 biologically independent samples, open symbols) mice, over four independent
experiments. Significant P values using two-tailed unpaired t test as follows: no. of total iNKT P= 0.0013, no. of NKT2 P= 0011 and % NKT2 P= 0.0011.
Flow cytometric detection (d) and quantitation (e) of total iNKT and iNKT subsets in LTβRTEC mice, 4 days after injection with either PBS (n= 8
biologically independent samples, closed symbols) or recombinant IL-25 (n= 7 biologically independent samples, open symbols), over three independent
experiments. Significant P values using two-tailed unpaired t test as follows: no. of NKT2 P= 0.0482. f WT thymocyte suspensions were cultured in the
presence (red line) or absence (black line) of recombinant IL-25 for the indicated period, and iNKT subsets were quantitated by flow cytometry. Data are
shown as mean percentage of input (i.e. cells at d0), and error bars indicate SEM of triplicate wells from one experiment, representative of three separate
experiments. All data are represented as mean ± SEM. *P < 0.05 and **P < 0.01. Source data are provided as a Source Data file.
a
b
c
d
e
f g
Fig. 6 IL-15 transpresentation stimulates survival and proliferation of
intrathymic iNKT1. a Schematic showing in vivo treatment of LTβRTEC mice
with PBS or IL-15/IL-15Rα complexes. b iNKT populations were analysed by
flow cytometry from LTβRTEC mice injected with PBS (top panel) or IL-15/
IL-15Rα complex (bottom panel) 4 days post injection. c Quantitation of
total iNKT and iNKT subsets in control (n= 12 biologically independent
samples, closed symbols) and IL-15/IL-15Rα injected mice (n= 9
biologically independent samples, open symbols) from five independent
experiments. Significant P values using two-tailed unpaired t test as follows:
no. of total iNKT P= 0.0035, no. of NKT1 P= 0.0031, no. of NKT17 P=
0.0012. d Schematic showing in vitro culture of WT thymocytes in the
absence or presence of IL-15/IL-15Rα complexes. e WT thymocyte
suspensions were cultured in the presence (red line) or absence (black line)
of IL-15/IL-15Rα complexes for the indicated period, and iNKT subsets were
quantitated by flow cytometry. Data are shown as mean percentage of
input (i.e. cells at d0), and error bars indicate SEM of triplicate wells from
one experiment, representative of three separate experiments. Significant
P values using two-tailed unpaired t test as follows: NKT1 day 1 P= 0.0008,
NKT1 day 2 P= 0.0034, NKT1 day 3 P= 0.0005. Analysis of intracellular
Bcl2 (f) and Ki67 (g) expression in untreated (black lines) and IL-15/IL-
15Rα-treated (red lines) NKT1 cells at day 3 of culture. Data shown
represent a minimum of three separate experiments. Significant P values
using two-tailed unpaired t test as follows: Bcl2 MFI P≤ 0.0001, % Ki67+
P= 0.0003. All data are represented as mean ± SEM. **P < 0.01, ***P <
0.001 and ****P < 0.0001. Source data are provided as a Source Data file.
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we analysed the functional significance of mTEClow heterogeneity
during intrathymic iNKT cell development, a known but poorly
understood function of the medulla.
Within adult mTEClow, we identified CD104+ cells uniformly
expressing the chemokine CCL21, as well as an additional and
distinct DCLK1+ subset. The latter was specifically contained
within CD104− cells and represents recently described thymic
tuft cells15,16. Thus, and in agreement with single-cell RNA-
sequencing data15,16, mTEClow are phenotypically heterogeneous.
To identify regulators of mTEClow heterogeneity, we created
LTβRTEC mice where the mTEC regulator LTβR was selectively
absent from TECs. Analysis showed that LTβR is essential for
thymic tuft cell differentiation, but is not an absolute requirement
for CD104+CCL21+ mTEClow differentiation. Instead, LTβR
influences the frequency of these cells. This reduction in CCL21+
mTEClow in LTβRTEC mice fits well with a similar observation in
germline Ltbr−/− mice26. Significantly, as the absence of LTβR
expression in the thymus of LTβRTEC mice is selective to TECs,
our findings extend these observations by demonstrating that
LTβR regulates CCL21+ mTEClow via a direct requirement for
LTβR expression by TECs. While the mechanism by which LTβR
regulates CCL21+ mTEClow is unclear, it may reflect the
importance of LTβR in controlling their proliferation and/or cell
turnover21,26. Alternatively, a requirement for LTβR by mTEC
progenitors39 may also impact the frequency of CD104+CCL21+
mTECs. Similarly, although our data shows an important
requirement for LTβR in thymic tuft cell development, the stage
(s) in the mTEC developmental pathway where LTβR is required
are not known. For example, tuft cell deficiency may be caused by
a requirement for LTβR in the development of immature mTEClo
progenitors that represent progenitors of mTEChi. Alternatively,
as thymic tuft cells can arise from mTEChi 15, defects in the
maturation of mTEChi towards more mature mTEClow stages
may be responsible for the absence of tuft cells. Perhaps, con-
sistent with this, mTEChi are also reduced in LTβRTEC mice22,
and germline Ltbr−/− mice that lack LTβR in all tissues also lack
terminally differentiated mTECs40. Finally, it is also interesting to
note that tuft cells themselves express detectable levels of LTβR
(Supplementary Fig. 1), so a further possibility is that LTβR directly
regulates tuft cells themselves, rather than in upstream stages of the
mTEC lineage. Thus, in current models of the mTEC develop-
mental pathway, that is, ‘bona fide’ mTEClow progenitors >mTE-
Chi > terminally differentiated mTEClow and tuft cells, it is not
currently known where the requirement for LTβR in tuft cell
development maps to, and tackling this question will require the
generation of new mouse models that enable gene targeting at
ba
Fig. 7 Impaired dendritic cell activation in LTβRTEC mice. Flow cytometric analysis of CD86 and MHCII expression by Lin−CD11c+Sirpα− cDC1 and
Lin−CD11c+Sirpα+ cDC2 in the thymuses of a Foxn1Cre (n= 10 biologically independent samples, closed symbols) and LTβRTEC (n= 11 biologically
independent samples, open symbols), and b WT (n= 7 biologically independent samples, closed symbols) Cd1d1−/− (n= 7 biologically independent
samples, open symbols). In both cases, graphs in lower panels show quantitation of MHCIIhiCD86hi cDC1 and cDC2 (gated as in upper panels). All data are
from three independent experiments. Significant P values using two-tailed unpaired t test are as follows: a cDC1 P= 0.0018, cDC2 P= 0.0014, b cDC1 P=
0.0001, cDC2 P= 0.0004. All data are represented as mean ± SEM. *** P < 0.001 and **P < 0.01. Source data are provided as a Source Data file.
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specific stages of the mTEC lineage. Nevertheless, that LTβR is an
essential regulator of thymic tuft cells provides important infor-
mation on a newly described and poorly understood TEC subset.
Interestingly, while thymic tuft cells are absent in both LTβRTEC
and Ltbr−/− germline mice, intestinal tuft cells are still present in
Ltbr−/− mice (Supplementary Fig. 5). Thus, despite shared simi-
larities of thymic and intestinal tuft cells, including their produc-
tion of IL-2515,41, they are generated via distinct developmental
pathways discriminated by a differential requirement for LTβR. As
such, these findings demonstrate a tissue-specific role for LTβR in
the control of tuft cells, with LTβRTEC mice providing a model in
which tuft cell deficiency is thymus specific.
When we assessed the relevance of the mTEClow heterogeneity
described above to αβT cell development, we saw a striking effect
on iNKT cells in LTβRTEC mice, which was explained by a
reduction in all NKT1, NKT2 and NKT17 lineages. This was in
contrast to unaltered programmes of conventional and Foxp3+
regulatory T cell development in LTβRTEC mice22. Thus, LTβR
expression by TECs is a selective and important controller of
intrathymic iNKT cell development. An interesting feature of the
iNKT cell defect in LTβRTEC mice is that all sublineages show a
comparable reduction, suggesting that LTβR does not control
lineage specification in iNKT cells. Rather, it may either influence
common iNKT cell progenitors42 or operate at later stages of
development by determining how mTECs regulate downstream
mature iNKT sublineages. In support of the latter, we found that
within the mTEClow subsets analysed here, CD104+CCL21+
mTEClow expressed the highest levels of both Il15 and Il15ra,
genes that are collectively required to enable IL-15 transpre-
sentation. Significantly, in vivo treatment of LΤβRTEC mice with
IL-15/IL-15R complexes was sufficient to increase both NKT1
and NKT17, indicating the reduction in these cells in LTβRTEC
mice is likely caused by limited IL-15 transpresentation. Together,
these findings suggest that NKT1 and NKT17 can be regulated by
IL-15 transpresentation. Importantly, these findings extend ear-
lier observations demonstrating a link between mTECs and
iNKT cells, and IL-15 transpresentation28. For example, this
earlier study did not examine the requirements of individual
NKT1, NKT2 and NKT17 subsets, nor did it assess the potential
functional importance of mTEClow subsets described here. Rele-
vant to this, while our study indicates that CD104+CCL21+
mTEClow are capable of IL-15 transpresentation, it is currently
unclear whether IL-15 transpresentation is limited to CD104+
CCL21+ mTEClow, or a property shared by other mTEC subsets.
Related to this, while analysis of IL-15CFP knock-in mice
demonstrated Il15 expression in mTEChi, expression of Il15ra
was not analysed in this study43. Relevant to this, we showed
previously28 that mTEChi express only very low levels of Il15ra in
comparison to mTEClow. Thus, while Il15 expression may be a
shared feature of multiple mTEC subsets, differential expression
of IL15Ra within mTEC may mean that IL-15Rα-mediated
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Fig. 8 LTβR expression by thymic epithelium determines peripheral
iNKT-pool size. a indicated that tissues from control Foxn1Cre and LTβRTEC
mice were analysed for iNKT cell frequencies by flow cytometry. Graphs in
b show cell percentages and number of iNKT cells per gram or ml of tissue,
as indicated, in Foxn1Cre (n= 7 biologically independent samples, closed
symbols) and LTβRTEC (n= 7 biologically independent samples, open
symbols), over three independent experiments. Significant P values using
two-tailed unpaired t test are as follows: % spleen P≤ 0.0001, % lung P=
0.0012, % liver P= 0.0494, % blood P= 0.0383, no. of cells in the spleen
P≤ 0.0001, no. of cells in the lung P= 0.0255, no. cells in the liver P=
0.0459, no. of cells in blood P= 0.0371. c Flow cytometric analysis of
intracellular IL-4 or IFNγ expression in splenic iNKT cells in Foxn1Cre (black
lines) and LTβRTEC (red lines) mice, 2 h after i.v. administration of αGal-Cer.
Grey histograms show levels of staining in non-injected mice. Percentages
(d) and numbers (e) of IL-4+ and IFNγ+ splenic iNKT after αGal-Cer
stimulation of Foxn1Cre (n= 7 biologically independent samples, closed
symbols) and LTβRTEC mice (n= 8 biologically independent samples, open
symbols), over three independent experiments. Significant P values using
two-tailed unpaired t test as follows: no. of IL-4+ cells P= 0.0011, no. of
IFNγ+ cells P= 0.0014. f shows ELISA quantitation of IL-4 (2 h post Gal-
Cer injection) Foxn1Cre (n= 7 biologically independent samples, closed
symbols) and LTβRTEC mice (n= 7 biologically independent samples, open
symbols), and IFNγ (16 h post Gal-Cer injection) in serum samples of
Foxn1Cre (n= 7 biologically independent samples, closed symbols) and
LTβRTEC mice (n= 6 biologically independent samples, open symbols),
over three independent experiments. Significant P values using two-tailed
unpaired t test are as follows: IL-4 P= 0.0117, IFNγ P≤ 0.0001. All data are
represented as mean ± SEM. *P < 0.05, **P < 0.01, and ****P < 0.0001.
Source data are provided as a Source Data file.
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transpresentation is more restricted. Direct analysis of this will
require the generation of new mouse models that allow selective
gene deletion in specific mTEC subsets. Regardless of how
widespread IL-15 transpresentation may be within mTEC, the
finding that CCL21+ mTEClow express genes that regulate IL-15
transpresentation extends our current understanding of the
involvement of this mTEC subset during T cell development. For
example, as well as controlling the CCL21-mediated entry of
conventional thymocytes into the medulla following positive
selection17, their regulation of NKT1 and NKT17 by IL-15
transpresentation highlights an additional functional property of
CD104+CCL21+ mTEClow and suggest that they act as regulators
of multiple αβT cell lineages in the thymus.
In analysing the intrathymic requirements of NKT2 cells, we
found that they expressed high levels of IL-17RB, a receptor for
the tuft cell-specific cytokine IL-25. Moreover, IL-25 treatment of
LTβRTEC mice increased NKT2 numbers in vivo. This correlated
with a selective NKT2 defect in tuft cell-deficient Pou2f3−/−mice,
where the intrathymic source of IL-25 is absent. That NKT2 cells
are reduced in the thymus of tuft cell-deficient Pou2f3−/− mice
fits well with a previous similar observation15. Importantly,
however, our study differs from this earlier report in several ways.
First, it is significant that the earlier study did not address the
mechanism by which tuft cells influence NKT2 cells. Here, we
show that as with Pou2f3−/− mice, iNKT2 are also reduced in the
thymus of Il25−/− mice. As thymic expression of IL-25 is
exclusive to tuft cells15,16 our data and that of others collectively
provide evidence for a mechanism in which tuft cells control
NKT2 cells via their IL-25 production. This scenario fits well with
the intrathymic restriction of IL-25 to tuft cells reported by both
Miller et al.15 and Bornstein et al.16, and is further supported by
experiments here showing increased NKT2 cells following in vivo
IL-25 administration. Second, and in contrast to Miller et al.15, we
found that NKT1 and NKT17 cells are not significantly reduced
in the thymus of Pou2f3−/−mice. The reasons for the discrepancy
in these findings on NKT1 and NKT17 cells are unknown.
However, as NKT1 cells lack IL-25 receptor expression, any
influence of tuft cells is unlikely to be explained by a requirement
for the tuft cell-specific product IL-25. In support of this, we
found that NKT1 cells were not significantly altered in Il25−/−
mice. Interestingly, while NKT17 cells do express dectectable
levels of IL-25 receptor, our analysis showing unaltered numbers
of NKT17 cells in tuft cell-deficient mice was paralleled by nor-
mal numbers of NKT17 cells in IL-25 -eficient mice. Thus, in our
hands, and unlike for NKT2 cells, tuft cells and IL-25 do not
appear to be essential regulators of either NKT1 or NKT17 cells.
Finally, despite our evidence indicating a role for IL-25 in reg-
ulating NKT2 cells in vivo, we found that IL-25 did not increase
NKT2 cells in vitro. Together, these findings suggest that through
the production of IL-25, tuft cells represent an important and
selective regulator of NKT2 cells, and that this cytokine operates
in synergy with other intrathymic signals to control their num-
bers. While the nature of these signals is not known, it is inter-
esting that IL-25 stimulates proliferation of splenic iNKT cells in
the presence of TCR stimulation31. As thymic iNKT cells show
evidence of ongoing TCR signalling7,9, and bone marrow-derived
thymic antigen-presenting cell express the iNKT cell receptor
ligand CD1d9, this raises the possibility that tuft cell production
of IL-25 operates in conjunction with TCR stimulation in the
thymus medulla to regulate NKT2 cells. Perhaps, relevant to this,
we found evidence for a functional consequence of reduced iNKT
cell development in LTβRTEC mice. Here, activation of intra-
thymic DCs was diminished, which mirrored DC defects in
Cd1d1−/− mice. How iNKT cells regulate thymic DC activation is
not clear. Indeed, while this study uses Cd1d1−/− mice to analyse
this requirement for iNKT cells, future analysis of Ja18−/− mice44
that exclusively lack type 1 iNKT cells may help to address this.
Whatever the case, this scenario fits well with the ability of
cytokine production by NKT2 cells (i.e. IL-4) to regulate the
expression of chemokines (CCL17 and CCL22) by thymic DCs7.
Alongside this impact of the NKT2-produced cytokine IL-4 on
thymic DCs, it may be the case that additional cytokines from
other iNKT subsets can also influence thymic DCs. For example,
it is tempting to speculate that intrathymic production of IFNγ, a
signature cytokine expressed by thymic NKT1 cells7 and known
regulator of DC activation45, may also be an explanation for how
iNKT cells regulate thymic DCs.
Finally, a striking finding in LTβRTEC mice was the reduction
in iNKT cells in both the thymus and multiple peripheral tissues.
These findings differ from previous studies on germline Ltbr−/−
mice, which showed reduced NKT cells in the liver and spleen,
but normal numbers in the thymus46,47. There are several pos-
sibilities to explain this discrepancy. First, in germline Ltbr−/−
mice peripheral lymphoid organ development is profoundly
disrupted, including the absence of lymph nodes and loss of
splenic organisation48, which may alter the survival and/or pro-
liferation of iNKT cells following their exit from the thymus.
Second, germline Ltbr−/− mice also have defects in thymus
emigration, which results in an intrathymic accumulation of
mature thymocytes21. Thus, a reduction in thymus emigration
could also explain the reduction in iNKT numbers in peripheral
tissues of germline Ltbr−/− mice. Consequently, these earlier
studies could not determine whether iNKT abnormalities caused
by germline LTβR deletion are a result of altered events in the
thymus or the periphery, or both. Importantly, in LTβRTEC mice,
selective intrathymic targeting of LTβR deletion to TEC with
Foxn1Cre directly demonstrates that loss of iNKT cells in these
mice is due to defective intrathymic development. Moreover,
unaltered thymus emigration in LTβRTEC mice49 also argues
against an impact on iNKT cells caused by defects in this process.
Thus, our data indicate that TEC expression of LTβR influences
intrathymic development of NKT cells in the thymus, and that
this then causes iNKT cell defects in the periphery.
Importantly, the defect in peripheral iNKT cells in LTβRTEC
mice is long lived and not accompanied by a recovery in their
numbers in peripheral tissues. In line with diminished peripheral
iNKT-pool size, we saw reduced levels of serum cytokine pro-
duction by peripheral iNKT cells following in vivo stimulation of
LTβRTEC mice with αGal-Cer. However, IL-4 and IFNγ produc-
tion by iNKT cells on a per cell basis was normal, suggesting that
defects in intrathymic maturation do not impair their response to
TCR stimulation. Why iNKT cell numbers do not recover in
peripheral tissues following defective thymus development is
unclear. One possibility is that undefined LTβR-dependent signals
are needed by iNKT cells during intrathymic maturation, and
their absence impairs long-term iNKT cell fitness in the periphery.
Alternatively, possible alterations in conventional or Foxp3+ T-reg
that might be caused by loss of LTβR may place iNKT cells at a
competitive disadvantage in peripheral tissues.
In conclusion, our study provides new evidence for the
importance of mTEClow heterogeneity in adult mice. Our iden-
tification of LTβR as a key regulator of multiple mTEClow subsets,
each controlling individual iNKT sublineages, helps redefine our
understanding of how the medulla influences non-conventional
αβT cells. Finally, that iNKT cell availability in multiple organs is
controlled through expression of LTβR by TECs demonstrates the
importance of the thymus in the regulation of the peripheral
immune system.
Methods
Mice. The following mice were sacrificed via cervical dislocation at 8–12 weeks of
age, unless otherwise indicated: WT mice on a C57BL/6 and BALB/c background
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were bred at the University of Birmingham, B6 Pou2f3−/−27 (RIKEN BioResource
Research Centre), germline Ltbr−/−48 (provided by Klaus Pfeffer, Heinrich
Heine University, Germany), CCL21tdTOM 17, B6 Cd1d1−/−50 (JAX), and BALB/c
Il25−/−51 (provided by Andrew McKenzie, LMB Cambridge). LTβRTEC mice were
generated by crossing Foxn1Cre mice38 with LTβRfl/fl mice52 (provided by Alexei
Tumanov, UT Health San Antonio, Texas). Foxn1Cre mice were used as controls
for LTβRTEC mice. All mice were co-housed in standard barrier conditions at the
Biomedical Services Unit at the University of Birmingham, and equal proportions
of male and female mice were used in all experiments. All mouse experiments were
done with permission from the Birmingham Animal Welfare and Ethical Review
Body and the UK Home Office.
Flow cytometry and cell sorting. For iNKT analysis, thymus, spleen and liver
samples were mechanically disrupted. Lungs were enzymatically digested using
Liberase TM (Roche, 12.5 μg/ml) and DNase I (100 mg/ml, Roche), and subse-
quently treated with Red Cell Lysis Buffer (Sigma). Cell suspensions were stained
with the following: anti-TCRβ (H57-597, eBioscience, cat. no.: 47-5961-82, 1:200),
anti-PLZF (Mags.21F7, eBioscience, cat. no.: 53-9320-82, 1:100), anti-RORγt (Q31-
378, Becton Dickinson, cat. no.: 564723, 1:100), anti-T-bet (4B10, eBioscience, cat.
no.: 50-5825-82, 1:100), anti-T-bet (4B10, BioLegend, cat. no.: 644820, 1:100), anti-
CD122 (TM-b1, eBioscience, cat. no.: 25-1222-82, 1:100), anti-IL-17RB (MUNC33,
eBioscience, cat. no.: 12-7361-82, 1:100) and CD1d tetramers loaded with PBS57 or
unloaded CD1d tetramers (obtained from the National Institutes of Health Tet-
ramer Facility). For stromal cell analysis, thymus tissue was digested with col-
lagenase dispase (2.5 mg/ml, Roche) and DNase I (40 mg/ml, Roche) and depleted
of CD45+ cells using anti-CD45 microbeads and LS columns (Miltenyi Biotec).
TECs were analysed using the following antibodies: anti-CD45 (30-F11,
eBioscience, cat. no.: 47-0451-82, 1:1000), anti-EpCAM1 (G8.8, eBioscience, cat.
no.: 46-5791-82, 1:2000), anti-Ly51 (6C3, eBioscience, cat. no.: 17-5891-82, 1:1000),
anti-IA/IE (M5/114.15.2, eBioscience, cat. no.: 56-5321-82, 1:2000), anti-CD80 (16-
10A1, BioLegend, cat. no.: 104729, 1:800) and anti-CD104 (346-11A, BioLegend,
cat. no.: 123610, 1:1000). Biotinylated UEA-1 (Vector Laboratories, B-1065,
1:10,000) was detected using streptavidin PECy-7 (eBioscience, cat. no.: 25-4317-
82, 1:1500). Intracellular detection of CCL21 and DCLK1 was achieved using anti-
CCL21 (Lifespan Biosciences, cat. no.: LS-C104634, 1:100) and anti-DCLK1
(DCAMKL1, Abcam, cat. no.: Ab31704, 1:1000), followed by donkey anti-rabbit
Alexa Fluor 488 (Invitrogen, cat. no.: A-21206, 1:1000). Thymic DCs were analysed
following digestion using collagenase D (2.5 mg/ml, Roche) and DNase I (40 mg/
ml, Roche), and stained with anti-CD11c (N418, eBioscience, cat. no.: 25-0114-82,
1:800), anti-PDCA-1 (129C1, BioLegend, cat. no.: 127018, 1:200), anti-Sirpα (P84,
eBioscience, cat. no.: 12-1721-82, 1:200), anti-IA/IE (M5/114.15.2, eBioscience, cat.
no.: 56-5321-82, 1:200) and anti-CD86 (GL1, BioLegend, cat. no.: 105035, 1:200).
Anti-CD3 (145-2C11, eBioscience, cat. no.: 47-0031-82, 1:200), anti-CD19
(eBio1D3, eBioscience, cat. no.: 47-0193-82, 1:200) and anti-NK1.1 (PK136,
eBioscience, cat. no.: 47-5941-82, 1:200) were used to create a lineage dump gate
prior to DC detection. All intracellular staining was performed using a
Foxp3 staining buffer set (eBioscience). Cultured thymocytes were analysed for
expression of Bcl2 and Ki67 using anti-Bcl2 (BCL/10C4, BioLegend, cat. no.:
635510, 1:100) and anti-Ki67 (SolA15, eBioscience, cat. no.: 25-5698-82, 1:2000).
Cells were analysed on an LSR Fortessa (Becton Dickinson), and data processed
using the FlowJo software (v.8 and v.10). The following TEC subsets were sorted
using a FACS Aria Fusion I (Becton Dickinson): CD104−mTEClow (CD45−
EpCAM+Ly51−UEA1+MHC-IIlowCD104−), CD104+mTEClow (CD45−EpCAM+
Ly51−UEA1+MHC-IIlowCD104+) and total mTEClow (CD45−EpCAM+Ly51−
UEA1+MHC-IIlowCD80low). Gating strategies for flow cytometry and sorting can
be found in Supplementary Fig. 6.
Confocal microscopy. Seven micrometre sections were cut from snap-frozen
thymus tissue, and then fixed in acetone. Antibodies used were: anti-DCLK1
(DCAMKL1, Abcam, cat. no.: Ab31704, 1:500), anti-CD8 (53-6.7, BioLegend, cat.
no.: MCD0821, 1:100), ERTR5 (hybridoma supernatant used undiluted)53. Sec-
ondary antibodies used were donkey anti-rabbit Alexa Fluor 555 (Invitrogen, cat.
no.: A-31572, 1:1000) and goat anti-rat IgM Alexa Fluor 488 (Invitrogen, cat. no.:
A-11006, 1:200). Sections were counterstained with DAPI (4′,6-diamidino-2-phe-
nylindole) (Sigma), and mounted using Prolong Diamond (Thermo Fisher). For
quantitation of iNKT cell positioning in thymus sections, whole thymus tissue was
incubated with phycoerythrin-conjugated PBS57-loaded CD1d tetramers over-
night, and then subsequently fixed in 2% paraformaldehyde (PFA) (Sigma) over-
night before freezing. Sections were incubated with rabbit anti-PE (Invitrogen, cat.
no.: 12-4739-81, 1:100), and then further amplified using donkey anti-rabbit Alexa
Fluor 555 (Invitrogen, cat. no.: A-31572, 1:1000). For quantitation of iNKT cell
positioning, iNKT cells were detected in thymus sections by CD1d tetramer
labelling and enumerated in 100 μm× 100 μm areas in the cortex and medulla. At
least three medullary and three cortical regions were analysed per section. Four
sections were analysed per mouse, obtained from differing depths throughout the
thymus, and three mice of each genotype were analysed. Detection of CCL21tdTOM
in sections was achieved by fixing whole thymus in 2% PFA/15% sucrose (Sigma)
for 4 h prior to freezing. Cryosections were stained without further amplification of
the CCL21tdTOM signal. Images were obtained using a Zeiss Zen 880 microscope,
and analysis was performed using the Zeiss Zen Black software.
Foetal thymus organ culture. Freshly isolated embryonic day 15 thymus lobes
were isolated from B6 embryos generated by timed matings, with the day of
detection of vaginal plug designated as day 0. Lobes were explanted onto the
surface of 0.8 μm Nucleopore filters (Thermo Fisher) and cultured in the presence
of 1.35 mM dGuo (Sigma)54. After 7 days, lobes were cultured for a further 4 days
in the presence or absence of 2 μg/ml agonistic anti-LTβR24, and then digested with
0.25% trypsin and 0.02% EDTA for either flow cytometric staining or qPCR
analysis.
Quantitative polymerase chain reaction. Briefly, high-purity complementary
DNA (cDNA) was obtained from mRNA labelled with oligo(dT) microbeads using
the μMacs One-step cDNA Kit, according to the manufacturer’s instructions
(Miltenyi Biotec). Real-time PCR was performed with SYBR Green with primers
specific for Actb (β-actin), Pou2f3, Dclk1, Trpm5, Ccl21a, Il25, Il15 and Il15ra on
the Corbett Rotor Gene-3000 PCR machine (Qiagen). PCRs were ran in replicates
using SensiMix SYBR No ROX Kit (Bioline) with 200 nM of primers for the genes
of interest (Sigma-Merck) and Actb primers (Qiagen, QT00095242). After an initial
polymerase activation step (95 °C for 10 min), cycling was performed for 40 cycles
at 95 °C for 15 s, 60–62 °C for 20 s, and 72 °C for 15 s. Amplification specificity was
verified by melt-curve analysis. Reaction amplification efficiencies and the Ct values
were obtained from the Rotor Gene Real-Time Analysis Software 6.1 using stan-
dard curves generated from mouse Universal cDNA Reference-oligo dT primed
(BioChain Institute). Fold levels shown in histograms represent the mean (±SEM)
of replicate reactions and data shown are representative of at least three inde-
pendently sorted sample sets. Primer sequences used:
Pou2f3: forward 5′-CTGGAACAGTAACGTCATCCTG-3′ and reverse
5′-AGTTCATTGCTGCTTTGGAGTT-3′;
Dclk1: forward 5′-GTTCCGTGGAAGTGGGGATG-3′ and reverse
5′-GCTATTACAGAAACTCCTGCTGC-3′;
Trpm5: forward 5′-CCAGCATAAGCGACAACATCT-3′ and reverse
5′-GAGCATACAGTAGTTGGCCTG-3′;
Ccl21a: forward 5′’-ATCCCGGCAATCCTGTTCTC-3′ and reverse
5′-GGGGCTTTGTTTCCCTGGG-3′;
Il25: forward 5′-TATGAGTTGGACAGGGACTTGA-3′ and reverse
5′-TGGTAAAGTGGGACGGAGTTG-3′;
Il15: forward 5′-TCTCCCTAAAACAGAGGCCAA-3′ and reverse
5′-TGCAACTGGGATGAAAGTCAC-3′;
Il15ra: forward 5′-CCCACAGTTCCAAAATGACGA-3′ and reverse
5′-GCTGCCTTGATTTGATGTACCAG-3′.
Actb (β-actin): QuantiTect Mm Actb 1SG Primer Assay (Qiagen, QT00095242).
αGal-Cer stimulation and flow cytometric cytokine detection. Mice were
injected intravenously with either 2 μg αGal-Cer (Abcam) or PBS, and harvested 2
h later for detection of IL-4 and IFNγ by flow cytometry and serum IL-4. For serum
detection of IFNγ, mice were harvested 16 h following αGal-Cer injection. Anti-IL-
4 (11B11, eBioscience, cat. no.: 17-7041-82, 1:100) and anti-IFNγ (XMG1.2, Bio-
Legend, cat. no.: 505813, 1:100) antibodies were used in conjunction with a
Cytofix/Cytoperm Kit (Becton Dickinson).
Serum cytokine detection. Mouse IL-4 and IFN-γ ELISA Deluxe Kits (BioLegend)
were used for quantification of cytokines in serum following in vivo αGal-Cer
stimulation. Samples were diluted for optimal detection.
In vitro cytokine stimulation. Enrichment of thymic iNKT cells was achieved
using anti-CD8 microbeads and LS columns (Miltenyi Biotec). Cells were cultured
in the presence of rIL-25 (BioLegend) or IL-15/IL-15Rα complexes, made by
mixing rIL-15 (Peprotech) and rIL-15Rα (R&D Systems) and incubating at 37 °C
for 30 min. For in vitro assays, the final concentrations were: rIL-25, 10 ng/ml; rIL-
15, 50 ng/ml; rIL-15Rα, 120 ng/ml.
In vivo cytokine stimulation. Mice were given a single intraperitoneal injection of
either PBS, rIL-25 (2.5 μg, BioLegend) or IL-15/IL-15Rα complexes (rIL-15: 2.5 μg,
Peprotech), rIL-15Rα: 15 μg, R&D Systems), and tissues were harvested and ana-
lysed 4 days later.
Statistical analysis. The GraphPad Prism software was used for all statistical
analysis. Unpaired two-tailed Student’s t tests were used for all statistical analysis.
Only P values < 0.05 were noted as significant. Nonsignificant differences were not
specified. Error bars in all figures represent SEM.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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